Discovery Life Sciences Appoints Executive Vice President to Support Rapid Progress in Proteomics

Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments

Advancing Precision Medicine: Emerging Trends in Spatial Biology

FDA Advisory Committee Challenges PD-1 Inhibitor Use in Gastric Cancer: The Rising Importance of PD-L1 Testing

The FDA LDT Rule is No More